• Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease : a survey among the Lipid Clinics NetworkCatapano, Alberico L.; Tokgozoglu, Lale; Banach, Maciej; Gazzotti, Marta; Olmastroni, Elena; Casula, Manuela; Ray, Kausik K.; Viigimaa, MargusAtherosclerosis2023 / p. 5 - 11 https://doi.org/10.1016/j.atherosclerosis.2023.02.007
• Lipoprotein(a) and Benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterolSchwartz, Gregory G.; Szarek, Michael; Bittner, Vera A.; Diaz, Rafael; Goodman, Shaun G.; Viigimaa, MargusJournal of the American College of Cardiology2021 / p. 421–433 : ill https://www.jacc.org/doi/epdf/10.1016/j.jacc.2021.04.102 https://doi.org/10.1016/j.jacc.2021.04.102
• 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias : Developed by the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Mach, François; Koskinas, Konstantinos C.; Roeters van Lennep, Jeanine E.; Tokgözoǧlu, Lale; Badimon, Lina; Baigent, Colin; Benn, Maianne; Binder, Christoph J.; Catapano, , Alberico L.; De Backer, Guy G.; Viigimaa, MargusEuropean Heart Journal2025 / p. 4359 - 4378 https://doi.org/10.1093/eurheartj/ehaf190 https://www.scopus.com/sourceid/23183 https://www.scopus.com/pages/publications/105021281761?origin=resultslist https://jcr.clarivate.com/jcr-jp/journal-profile?journal=EUR%20HEART%20J&year=2024 https://www.webofscience.com/wos/woscc/full-record/WOS:001560858200001